Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) Gross Margin (2021 - 2025)

Historic Gross Margin for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to 65.16%.

  • MDxHealth's Gross Margin rose 39400.0% to 65.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year decrease of 616300.0%. This contributed to the annual value of 55.5% for FY2024, which is 70800.0% down from last year.
  • Latest data reveals that MDxHealth reported Gross Margin of 65.16% as of Q3 2025, which was up 39400.0% from 0.03% recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Gross Margin registered a high of 65.32% during Q4 2023, and its lowest value of 0.03% during Q2 2025.
  • Its 5-year average for Gross Margin is 54.16%, with a median of 59.66% in 2023.
  • Per our database at Business Quant, MDxHealth's Gross Margin skyrocketed by 130900bps in 2023 and then plummeted by -599300bps in 2025.
  • MDxHealth's Gross Margin (Quarter) stood at 46.35% in 2021, then rose by 21bps to 56.04% in 2022, then rose by 17bps to 65.32% in 2023, then dropped by -4bps to 62.72% in 2024, then rose by 4bps to 65.16% in 2025.
  • Its Gross Margin stands at 65.16% for Q3 2025, versus 0.03% for Q2 2025 and 63.82% for Q1 2025.